ETOR Q1 2026 Earnings EPS Surges Past Estimates by 234 Revenue Details Remain Undisclosed CRISPR Therapeutics Q1 2026 Earnings Slight EPS Miss as Clinical Pipeline Progresses Ziff Davis Q1 2026 Earnings EPS Misses Estimates Stock Rises 475 HMY Q2 2016 Earnings EPS Miss by 5475 Yet Stock Rallies 716 LOMA Q1 2026 Earnings Strong EPS of 3505 Despite Negative Stock Reaction LII Q1 2026 Earnings EPS Surpasses Estimates Stock Moves Higher